Concord Medical Services (NYSE:CCM) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued to clients and investors on Saturday. The firm set a “sell” rating on the stock.

Concord Medical Services Stock Up 3.1 %

NYSE CCM opened at $5.70 on Friday. The company’s 50-day moving average price is $6.91 and its 200-day moving average price is $6.68. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.30 and a current ratio of 0.32. Concord Medical Services has a 12 month low of $3.82 and a 12 month high of $26.70.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.